The isoform-selective PI3Kδ inhibitor CAL-101, possessing a purine quinazolinone scaffold with the propeller-type conformation, has been identified to inhibit pre-rRNA synthesis and proliferation of AML cells through totally suppressing Akt phosphorylation [25]. This evidence concerns the gene AKT1 and acute myeloid leukemia.